Figure 2: Novel Incretin Mimetic Assets for T2DM and Obesity in Phase 2/3 of Development Remaining Unmet Needs Remaining Unmet Needs Though the value proposition of on-market GLP-1 and dual-agonists is strong, several key unmet needs still exist for incretin mimetics across diabetes and obesity, namely: (1) improved efficacy, (2) better tolerability, (3) more convenient options / alternative ROAs, and (4) improved access and affordability
Participants with diabetes or active cardiovascular disease were excluded, as were those pregnant or with uncontrolled comorbidities
Three tretinoin strengths let you titrate irritation vs efficacy 3
Protein powder (check label, typically 20-30g per scoop), Greek yogurt (15-18g per cup), milk (8-13g per cup depending on type), nut butter (4-7g per tablespoon)
10.1007/BF03179824
Love the product Fast, friendly and my go to